🇺🇸 SP, amodiaquine, piperaquine, dihdroartemisinin in United States

FDA authorised SP, amodiaquine, piperaquine, dihdroartemisinin on 28 October 1981

Marketing authorisation

FDA — authorised 28 October 1981

  • Application: NDA018557
  • Marketing authorisation holder: ROCHE
  • Local brand name: FANSIDAR
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Frequently asked questions

Is SP, amodiaquine, piperaquine, dihdroartemisinin approved in United States?

Yes. FDA authorised it on 28 October 1981.

Who is the marketing authorisation holder for SP, amodiaquine, piperaquine, dihdroartemisinin in United States?

ROCHE holds the US marketing authorisation.